Volume
Open
Day's Low
Day's High
52 Wk Low
52 Wk High
Bid
Ask
EPS
PE Ratio
Shares
Market Cap
Dividend
Ex-Div Date
Yield
Interested in Gold Updates?
Receive the latest updates on the gold and silver markets.
...
Health Technology » Biotechnology
| symbol | company | %chng | last | %short | avg$volume | |
|---|---|---|---|---|---|---|
| MRNA | Moderna, Inc. | 6.84% | 170.81 | 0.0% | $1433.85m | |
| AMGN | Amgen, Inc. | 0.23% | 255.71 | 1.3% | $690.21m | |
| NVAX | Novavax, Inc. | 12.50% | 227.35 | 80.0% | $655.57m | |
| SNSS | Sunesis Pharmaceuticals, Inc. | -0.37% | 8.00 | 0.7% | $559.23m | |
| ILMN | Illumina, Inc. | -0.74% | 399.00 | 3.5% | $519.65m | |
| GILD | Gilead Sciences, Inc. | 1.67% | 66.87 | 1.0% | $470.50m | |
| REGN | Regeneron Pharmaceuticals, Inc. | 1.61% | 502.60 | 2.7% | $458.74m | |
| VRTX | Vertex Pharmaceuticals, Inc. | -0.77% | 219.39 | 1.9% | $388.60m | |
| ALXN | Alexion Pharmaceuticals, Inc. | 3.90% | 163.68 | 2.0% | $348.10m | |
| BNTX | BioNTech SE | 7.69% | 151.54 | 0.0% | $313.57m | |
| BIIB | Biogen, Inc. | -0.05% | 270.31 | 1.7% | $263.29m | |
| EXAS | EXACT Sciences Corp. | -0.37% | 130.04 | 18.4% | $186.19m | |
| NBIX | Neurocrine Biosciences, Inc. | 1.66% | 96.58 | 4.9% | $179.73m | |
| CRSP | CRISPR Therapeutics AG | -4.27% | 118.56 | 0.6% | $166.57m | |
| SGEN | Seagen Inc. | -2.77% | 145.50 | 5.8% | $146.84m |
Company Profile
Curis, Inc. engages in the development and commercialization of drug candidates for the treatment of human cancers. Its pipeline includes CUDC-907, CA-4948, CA-170 and CA-327. The CUDC-907 pipeline is an orally available small molecule inhibitor of HDAC and PI3K enzymes. The CA-170 pipeline is an also an orally-available small molecule antagonist of PD-L1 and VISTA immune checkpoints. The company was founded on February 14, 2000 and is headquartered in Lexington, MA.